Scientific Program – GynecologyFriday, November 22, 2024 |
 |
| 08:30-09:00 | GOOD MORNING LISBON PLENARY LECTURE | HALL A |
| 09:00-10:30 | ENDOMETRIOSIS | HALL C |
| Capsule | Early identification and treatment of endometriosis improves reproductive health | |
| Chairpersons | George Creatsas, Greece Eileen Manalo, Philippines |
|
| 09:00-09:20 | Mechanisms of endometriosis related infertility Marie-Madeleine Dolmans, Belgium |
|
| 09:20-09:45 | Oral GnRH Antagonist for treatment of endometriosis Pedro Pinto, Portugal |
|
| 09:45-10:05 | Recurrence after surgery. How often? How to manage? Jacques Donnez, Belgium |
|
| 10:05-10:30 | Is TLH really superior to abdominal hysterectomy? Jessica Ybanez Morano, USA |
|
| 10:30-10:50 | Coffee break, visit the exhibition, and e-poster viewing |
| 10:50-12:20 | CONTRACEPTION | HALL C |
| Capsule | The supremacy of combined OC’s is being challenged by a more personal approach of tailoring a solution according to patient’s conditions | |
| Chairpersons | Alessandra Graziottin, Italy Herjan Coelingh Bennink, Netherlands |
|
| 10:50-11:10 |
Cardiovascular risk and hormonal contraception: Yes or no! First choice Or Progestin only pills |
|
| 11:10-11:35 |
Contraception and endometriosis |
|
| 11:35-11:55 |
Adolescent contraception |
|
| 11:55-12:20 |
E4 for contraception |
|
| 12:20-12:25 | Short break |
| 12:25-13:25 | INDUSTRY SUPPORTED SESSION | HALL A |
| 13:25-14:10 | Lunch break, visit the exhibition, e-poster viewing, and moderated e-poster sessions |
| 14:10-15:10 | ORAL PRESENTATIONS SESSION 4 | HALL C |
| 15:10-15:15 | Short break |
| 15:15-16:45 | GYNECOLOGICAL ONCOLOGY | HALL C |
| Capsule | Cancer patients should be informed of options for fertility preservation and future reproduction prior to cancer treatment (ASRM). However, gynecologists should be more aware of the current options and results. | |
| Chairpersons | Fátima Faustino, Portugal Mark Brincat, Malta |
|
| 15:15-15:45 |
Fertility- sparing management in recurrent gynecological cancer |
|
| 15:45-16:15 |
Fertility-sparing management in young endometrial cancer patients |
|
| 16:15-16:45 |
Controversies in vaginal recurrence of cervical and endometrial cancer |
|
| 16:45-17:05 | Coffee break, visit the exhibition, and e-poster viewing |
| 17:05-18:35 | GENITOURINARY SYNDROME OF MENOPAUSE (GSM) | HALL C |
| Capsule |
Genitourinary syndrome of menopause (GSM) formerly “atrophic vaginitis” includes genital symptoms of dryness, burning, and irritation, sexual symptoms of lack of lubrication, discomfort, pain, impaired function and urinary symptoms of urgency, dysuria and recurrent urinary tract infections. What is the best treatment? |
|
| Chairpersons | Mark Brincat, Malta Franco Borruto, Monaco |
|
| 17:05-17:40
17:05-17:15 |
Debate: Laser treatment is the first-line choice for Genitourinary Syndrome of Menopause (GSM)? Yes: Zdenko Vizintin, Slovenia |
|
| 17:40-18:00 |
Anatomical and physiological changes of the vulvovaginal tract during peri-menopause |
|
| 18:00-18:20 |
Can lasers reduce overactive bladder symptoms? |
|
| 18:20-18:35 |
Vaginal aplasia – vaginoplasty |
|
